Event recap

World Drug Safety Congress EU

shutterstock_706301668

Key takeaways and insights

The World Drug Safety Congress Europe convened industry leaders to explore new approaches to strengthening drug safety — from advancements in AI and quality assurance to more effective signal management. At the congress, our experts shared case studies on how outsourcing drug safety from protocol to patient can enhance patient safety while reducing cost and effort, and we valued the opportunity to connect with peers to discuss the safety processes that matter most.

A key highlight was the work featured by Ian Barnden, PV Business Partner, Digital Innovation, Cencora, on how automation can increase efficiency and accuracy in local PV monitoring and KPI tracking. His session explored a validated system that automates the collection and reporting of local pharmacovigilance metrics and KPIs across 100+ countries, improving consistency and accuracy while reducing administrative burden so PV specialists can stay focused on critical safety issues.

With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise

3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented

Helping breakthroughs break through
 

At Cencora, we’re leading the way to a place where your life-changing therapies can soar to impossible heights. Together, let’s create healthier futures for more patients around the globe.
A group of doctors in a meeting

Maximize patient safety and minimize risk throughout your product life cycle

Patient safety is a primary mandate of every health authority worldwide and we know that pharmacovigilance (PV) teams are facing growing operational challenges and resource constraints. That's why we offer local and global pharmacovigilance services to improve the success of product launches and post-market growth, while freeing up safety and clinical teams to focus on strategic priorities. Our customers gain a competitive edge with access to more than 1000 subject matter experts and native resources in over 150 countries.

Join us for this on-demand webinar

How full pharmacovigilance outsourcing increases efficiency and accuracy

In the face of increasing market pressures and an uncertain global environment, biopharmaceutical companies are seeking new avenues to help optimize efficiencies and cost structures. Leading organizations are finding success by shifting from functional outsourcing for pharmacovigilance areas such as case processing to a complete end-to-end pharmacovigilance outsourcing model.

Connect with our team

Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.